Aperio Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,493
Closed 3034
2019
Q2
$0 Buy
+1,493
New +$4.03K ﹤0.01% 3069

Aperio Group's INSY Position: Q3 2019 in Review

Aperio Group sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 1,493 shares.

Aperio Group first reported a position in INSY in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

  • Aperio Group reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Aperio Group sold 1,493 Insys Therapeutics, Inc. shares in Q3 2019.
  • Aperio Group first reported a position in Insys Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
  • Aperio Group's Insys Therapeutics, Inc. position peaked at $0 in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.